loading
前日終値:
$7.06
開ける:
$7.05
24時間の取引高:
61,297
Relative Volume:
0.80
時価総額:
$656.03M
収益:
$106.66M
当期純損益:
$15.16M
株価収益率:
72.83
EPS:
0.0935
ネットキャッシュフロー:
$6.37M
1週間 パフォーマンス:
-6.20%
1か月 パフォーマンス:
-10.16%
6か月 パフォーマンス:
-12.69%
1年 パフォーマンス:
-43.25%
1日の値動き範囲:
Value
$6.76
$7.055
1週間の範囲:
Value
$6.76
$7.265
52週間の値動き範囲:
Value
$6.11
$13.75

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Name
名前
Gyre Therapeutics Inc
Name
セクター
Healthcare (1131)
Name
電話
(858) 567-7770
Name
住所
12770 HIGH BLUFF DRIVE, SAN DIEGO
Name
職員
574
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
GYRE's Discussions on Twitter

GYRE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GYRE
Gyre Therapeutics Inc
6.81 680.11M 106.66M 15.16M 6.37M 0.0935
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.13 115.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
776.31 81.12B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
400.17 52.54B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
839.99 51.78B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
177.12 37.12B 447.02M -1.18B -906.14M -6.1812

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 開始されました Jefferies Buy
2025-08-26 開始されました H.C. Wainwright Buy
2025-03-11 開始されました Noble Capital Markets Outperform
2021-04-29 再開されました Stephens Overweight
2021-02-10 開始されました Piper Sandler Overweight
2020-05-21 開始されました Raymond James Outperform
2019-01-04 開始されました Oppenheimer Outperform
2018-02-12 繰り返されました B. Riley FBR, Inc. Buy
2018-02-09 繰り返されました Chardan Capital Markets Buy
2017-12-08 開始されました B. Riley FBR, Inc. Buy
2017-06-12 開始されました Chardan Capital Markets Buy
2017-06-06 開始されました Ladenburg Thalmann Buy
2016-06-30 開始されました Rodman & Renshaw Buy
すべてを表示

Gyre Therapeutics Inc (GYRE) 最新ニュース

pulisher
Dec 26, 2025

Undiscovered Gems in the US Market to Explore This December 2025 - Yahoo Finance

Dec 26, 2025
pulisher
Dec 21, 2025

Published on: 2025-12-21 18:19:37 - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.6% – Time to Sell? - Defense World

Dec 21, 2025
pulisher
Dec 20, 2025

Will Gyre Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Breakouts & Low Drawdown Investment Strategies - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Gyre Therapeutics Earnings Notes - Trefis

Dec 19, 2025
pulisher
Dec 19, 2025

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.6%Time to Sell? - MarketBeat

Dec 19, 2025
pulisher
Dec 19, 2025

Why Gyre Therapeutics Inc. stock remains on buy lists2025 Trading Recap & Long-Term Capital Growth Strategies - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Levels Update: Is Gyre Therapeutics Inc. stock vulnerable to regulatory risks2025 Major Catalysts & Weekly Momentum Picks - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Will Gyre Therapeutics Inc. stock deliver consistent dividends2025 Market WrapUp & Reliable Price Action Trade Plans - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Does Gyre Therapeutics Inc. stock trade at a discount to peers2025 Geopolitical Influence & AI Driven Price Forecasts - Улправда

Dec 18, 2025
pulisher
Dec 15, 2025

Gyre therapeutics president Ma Songjiang sells $45,434 in stock - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

US High Growth Tech Stocks to Watch - Yahoo Finance

Dec 15, 2025
pulisher
Dec 13, 2025

Gyre Therapeutics president Ma Songjiang sells $42,480 in stock - MSN

Dec 13, 2025
pulisher
Dec 12, 2025

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 5.9%Should You Sell? - MarketBeat

Dec 12, 2025
pulisher
Dec 10, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Dec 10, 2025
pulisher
Dec 10, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Dec 10, 2025
pulisher
Dec 09, 2025

GNI Group’s Subsidiary Completes Enrollment for Key Clinical Trial - MSN

Dec 09, 2025
pulisher
Dec 09, 2025

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 2.3%Time to Buy? - MarketBeat

Dec 09, 2025
pulisher
Dec 07, 2025

Gyre Therapeutics (GYRE) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 07, 2025
pulisher
Dec 04, 2025

Is Gyre Therapeutics Stock Built to Withstand a Pullback? - Trefis

Dec 04, 2025
pulisher
Nov 30, 2025

Regarding video postings related to our company group information on some social networking services (SNS). - 富途牛牛

Nov 30, 2025
pulisher
Nov 26, 2025

Published on: 2025-11-27 08:38:09 - moha.gov.vn

Nov 26, 2025
pulisher
Nov 23, 2025

Is Gyre Therapeutics Inc a good long term investmentMarket Depth Overview & Free Unmatched Market Performance - earlytimes.in

Nov 23, 2025
pulisher
Nov 21, 2025

Is Gyre Therapeutics Inc. stock a dividend growth opportunity2025 Short Interest & Real-Time Volume Triggers - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Gyre Therapeutics Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Safe Entry Point Identification - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What drives Gyre Therapeutics Inc stock priceMarket Capitalization Trends & Free Triple Digit Wealth Increase - earlytimes.in

Nov 21, 2025
pulisher
Nov 21, 2025

Will Gyre Therapeutics Inc. stock return to pre crisis levelsLong Setup & Low Risk High Win Rate Picks - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Should I hold or sell Gyre Therapeutics Inc. stock in 2025July 2025 Final Week & Verified Technical Signals - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Why Gyre Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What recovery options are there for Gyre Therapeutics Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Gyre Therapeutics Inc. stock sustain institutional interest2025 Biggest Moves & Smart Money Movement Tracker - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Gyre Therapeutics Inc. stock performs in interest rate cyclesMarket Activity Recap & Daily Volume Surge Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Gyre Therapeutics Inc. stock entering bullish territoryTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives $17.00 Average PT from Brokerages - Defense World

Nov 18, 2025

Gyre Therapeutics Inc (GYRE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Gyre Therapeutics Inc (GYRE) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Ma Songjiang
President
May 27 '25
Sale
10.28
2,000
20,560
2,806,642
Ma Songjiang
President
May 28 '25
Sale
10.07
558
5,619
2,806,084
Ma Songjiang
President
May 22 '25
Sale
10.97
2,000
21,940
2,808,824
Ma Songjiang
President
May 23 '25
Sale
10.24
182
1,864
2,808,642
Ma Songjiang
President
May 20 '25
Sale
11.25
2,000
22,500
2,812,824
Ma Songjiang
President
May 21 '25
Sale
10.83
2,000
21,660
2,810,824
Ma Songjiang
President
May 16 '25
Sale
11.31
2,000
22,620
2,816,824
Ma Songjiang
President
May 19 '25
Sale
11.11
2,000
22,220
2,814,824
Ma Songjiang
President
May 15 '25
Sale
10.68
2,000
21,360
2,818,824
Ma Songjiang
President
May 14 '25
Sale
11.30
20
226
2,820,824
$38.86
price up icon 0.57%
$31.82
price up icon 3.31%
$101.42
price up icon 2.68%
$96.69
price up icon 1.57%
biotechnology ONC
$311.02
price up icon 2.37%
$177.12
price up icon 1.77%
大文字化:     |  ボリューム (24 時間):